“许多专家关注聚乙二醇干扰素治疗过程中HBeAg或HBsAg滴度的动态变化,认为这种量的变化往往是抗原消失或血清转换的前提,具有疗效预测作用。”
另外还有一篇发表于Hepatology(07年影响因子>10)的文献:
Fried MW, Piratvisuth T, Lau GK, et al. HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B. Hepatology, 2008,47:428-34.
http://www.diasorin.com/en/internationalcatalog/list/222
LIAISON® HBeAg 310150
Intended use: For the quantitative determination of Hepatitis B e Antigen (HBeAg)
Material provided: Reagent integral for 100 determinations.
Method: 1 step immunoluminometric sandwich assay using directly coated magnetic microparticles
Calibrators: Included (PEI, HBe Reference Antigen 82 Preparation)
Incubations: 20 min
Sample type: Serum/Plasma